BRCA1 and ovarian carcinoma: This well-described mechanistic epistasis can give rise to a more abstract statistical epistasis: mutations in TP53 are found nearly twice as often in ovarian cancers with BRCA1 or BRCA2 mutations compared with tumors with wild-type BRCA1 and BRCA2 [72, 73].